Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer submits colitis drug application to FDA, EMA
07:45am, Wednesday, 21'st Dec 2022
Pfizer Inc. PFE, -0.08% said Wednesday that the Food and Drug Administration and the European Medicines Agency accepted the new drug application for its ulcerative colitis treatment candidate. The FDA
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:32am, Tuesday, 20'th Dec 2022
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
10:00am, Tuesday, 20'th Dec 2022
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, J
Pfizer gains rights to experimental RSV treatment in China, Hong Kong, Macau and Singapore
08:30am, Monday, 19'th Dec 2022
Pfizer Inc. PFE, -4.12% said Monday that it will help develop and commercialize sisunatovir, LianBio's LIAN, +7.14% experimental respiratory syncytial virus (RSV) treatment candidate, in mainland Chin
Pfizer and BioNTech fast tracked by FDA for combined COVID, flu vaccine
11:49am, Friday, 16'th Dec 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss China's reopening challenges as COVID cases rise as well as the latest surrounding Pfizer and BioNTech's combined COVID and flu vaccine.
Is Pfizer Stock A Better Pick Over This Pharmaceuticals Bellwether?
06:00am, Friday, 16'th Dec 2022
We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to 4.9x
Why Pfizer Stock Is Riskier Than AbbVie
05:52am, Friday, 16'th Dec 2022
Pfizer has a lot more revenue at risk over the next several years than AbbVie does.
2 Dividend Stocks That Could Double Your Return in 10 Years
05:05am, Friday, 16'th Dec 2022
Both companies should hurdle their patent cliff concerns.
Jim Cramer recommends these 5 healthcare stocks in 2023
07:06pm, Thursday, 15'th Dec 2022
Cramer said that healthcare stocks have stayed relatively steady this year because they tend to be recession-resistant stocks.
China approves sale of Pfizer COVID pill Paxlovid as cases surge, White House denies involvement
06:00pm, Thursday, 15'th Dec 2022
The White House says it was not in any way involved in China's approval of Pfizer's COVID-19 pill to treat an anticipated wave of infections.
7 Cheap Retirement Stocks to Buy Now
12:45pm, Thursday, 15'th Dec 2022
While the thought of being an AARP cardmember may be far away, it's never too early to start thinking about cheap retirement stocks to buy. True, timing the market carries risks.
My 2022 Top 5 Beat By >10%, Plus My Top Buys For 2023
10:38pm, Wednesday, 14'th Dec 2022
My top 5 picks for 2022 outperformed the S&P 500 by over 14%. I provide an update for those stocks in this article, two of which remain top picks for the coming year.
Pfizer: The Best Long-Term Investment Setup Since 2009
11:22am, Monday, 12'th Dec 2022
Pfizer has a history of performing well during recessions and bear markets on Wall Street. COVID-19 sales may remain high, longer than expected.
Dividend Champion, Contender, And Challenger Highlights: Week Of December 11
05:29am, Sunday, 11'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates and pay dates.
This fund beats the S&P 500 by using just 75 of its components. Here's how it works.
05:39pm, Saturday, 10'th Dec 2022 MarketWatch
A combination of quality and lower prices has worked well through bull and bear markets — it may be just the ticket for investors worried about a recession.
